{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:56:19Z","timestamp":1792806979374,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","funder":[{"name":"Cleveland Clinic Caregiver Catalyst Grant","award":["CCG 0093"],"award-info":[{"award-number":["CCG 0093"]}],"id":[{"id":"https:\/\/ror.org\/03xjacd83","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Kidney biopsy registries in the United States are lacking.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>We provide a multicenter, multistate kidney biopsy database in the United States and identified demographic and clinical trends.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Our study catalogs the spectrum of biopsy-proven kidney disease across the Cleveland Clinic enterprise andhighlights the need for a standardized national kidney biopsy registry to bolster glomerular and kidney disease research in the United States.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The kidney biopsy is the gold standard for diagnosing glomerular diseases. Large-scale, epidemiologic studies describing the prevalence of kidney diseases are lacking, especially in the United States. We aimed to determine the spectrum of biopsy-proven kidney disease across the Cleveland Clinic enterprise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified all patients with a native kidney biopsy performed or reviewed at the Cleveland Clinic from January 2015 to September 2021. Retrospective chart review was performed to obtain clinical and demographic characteristics. Results were stratified by age, sex, race, and location to determine epidemiologic trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of &gt;9600 patients, we excluded transplant and donor biopsies and unavailable records, and included 4128 patients with native kidney biopsy data. The median age was 60 years, with 46% female patients. Self-reported racial demographics included 73% White, 22% Black, 3% multiracial, and 2% Asian background, with 5% Hispanic. Common diagnoses were: FSGS (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =633, 15%), diabetic kidney disease (DKD) (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =602, 15%), IgA nephropathy (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =319, 8%), lupus nephritis (LN) (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =289, 7%), pauci-immune glomerulonephritis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =275, 7%), membranous nephropathy (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =211, 5%), and amyloidosis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =110, 3%). There were 3322 patients in Ohio, with 361 patients in Florida. Using multivariate analysis, those aged &gt;70 years were more likely to have FSGS, whereas those &lt;45 years were more likely to have IgA nephropathy or LN. Males were more likely to have FSGS or IgAN, and less likely to have LN. Black patients were more likely to have FSGS, DKD, or LN. Hispanic patients were more likely to have DKD. Finally, patients in Florida were more likely to have LN. There was no change in the disease spectrum before and during the COVID-19 pandemic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study catalogs the spectrum of biopsy-proven kidney disease across the Cleveland Clinic enterprise. This lays the foundation for glomerular disease clinical trials, and highlights the need for a standardized national kidney biopsy registry to bolster glomerular and kidney disease research in the United States.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0005882022","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T08:55:14Z","timestamp":1666169714000},"page":"2077-2085","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["The Cleveland Clinic Kidney Biopsy Epidemiological Project"],"prefix":"10.34067","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6830-0948","authenticated-orcid":false,"given":"Shane A.","family":"Bobart","sequence":"first","affiliation":[{"name":"Department of Kidney Medicine, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Portalatin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Sawaf","sequence":"additional","affiliation":[{"name":"Department of Kidney Medicine, Cleveland Clinic Ohio, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Shettigar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Carrion-Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9148-8894","authenticated-orcid":false,"given":"Hong","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2665-8559","authenticated-orcid":false,"given":"Leal","family":"Herlitz","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Cleveland Clinic Ohio, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surafel K.","family":"Gebreselassie","sequence":"additional","affiliation":[{"name":"Department of Kidney Medicine, Cleveland Clinic Florida, Weston, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"B1-20250825","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ndt\/gfy220","article-title":"Standardized classification and reporting of glomerulonephritis","volume":"34","author":"Sethi","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"B2-20250825","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2021.01.002","article-title":"US Renal Data System 2020 Annual Data Report: Epidemiology of kidney disease in the United States","volume":"77","author":"Johansen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"B3-20250825","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12882-021-02365-3","article-title":"Coding practice in national and regional kidney biopsy registries","volume":"22","author":"Dendooven","year":"2021","journal-title":"BMC Nephrol"},{"key":"B4-20250825","first-page":"205","article-title":"Characterization of kidney lesions in Indian adults: Towards a renal biopsy registry","volume":"19","author":"Narasimhan","year":"2006","journal-title":"J Nephrol"},{"key":"B5-20250825","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2215\/CJN.10871016","article-title":"Temporal and demographic trends in glomerular disease epidemiology in the Southeastern United States, 1986-2015","volume":"12","author":"O\u2019Shaughnessy","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B6-20250825","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1681\/ASN.2015060612","article-title":"Mayo Clinic\/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN","volume":"27","author":"Sethi","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 1","key":"B8-20250825","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.02.001","article-title":"US Renal Data System 2021 Annual Data Report: Epidemiology of kidney disease in the United States","volume":"79","author":"Johansen","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"B9-20250825","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B10-20250825","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1681\/ASN.2015121308","article-title":"Renal aging: Causes and consequences","volume":"28","author":"O\u2019Sullivan","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B11-20250825","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tem.2016.02.002","article-title":"Apolipoprotein L1 and kidney disease in African Americans","volume":"27","author":"Friedman","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"3S2","key":"B12-20250825","first-page":"S34","article-title":"Lupus nephritis - An update on disparities affecting African Americans","volume":"114","author":"Portalatin","year":"2022","journal-title":"J Natl Med Assoc"},{"key":"B13-20250825","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mayocp.2020.11.028","article-title":"A target antigen-based approach to the classification of membranous nephropathy","volume":"96","author":"Bobart","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"B14-20250825","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ki.2012.428","article-title":"Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach","volume":"83","author":"Gadegbeku","year":"2013","journal-title":"Kidney Int"},{"key":"B15-20250825","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2215\/CJN.00710805","article-title":"Changing incidence of glomerular disease in Olmsted County, Minnesota: A 30-year renal biopsy study","volume":"1","author":"Swaminathan","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B16-20250825","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40620-014-0090-z","article-title":"Nationwide biopsy survey of renal diseases in the Czech Republic during the years 1994-2011","volume":"28","author":"Maixnerova","year":"2015","journal-title":"J Nephrol"},{"key":"B17-20250825","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/ckj\/sfac033","article-title":"Epidemiology of native kidney disease in Flanders: Results from the FCGG kidney biopsy registry","volume":"15","author":"Laurens","year":"2022","journal-title":"Clin Kidney J"},{"key":"B18-20250825","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1523-1755.2004.00831.x","article-title":"The Italian experience of the national registry of renal biopsies","volume":"66","author":"Gesualdo","year":"2004","journal-title":"Kidney Int"},{"key":"B19-20250825","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1523-1755.2004.00832.x","article-title":"The Danish renal biopsy register","volume":"66","author":"Heaf","year":"2004","journal-title":"Kidney Int"},{"key":"B20-20250825","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2215\/CJN.02150212","article-title":"Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010","volume":"7","author":"T\u00f8ndel","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl_2","key":"B21-20250825","doi-asserted-by":"crossref","first-page":"ii209","DOI":"10.1093\/ndt\/gfw365","article-title":"Clinicopathologic correlations of renal pathology in the adult population of Poland","volume":"32","author":"Perkowska-Ptasinska","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B22-20250825","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/ndt\/gfn677","article-title":"Centre variation in incidence, indication and diagnosis of adult native renal biopsy in Scotland","volume":"24","author":"McQuarrie","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B23-20250825","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1523-1755.2004.00835.x","article-title":"Signs and symptoms of thin basement membrane nephropathy: A prospective regional study on primary glomerular disease-The Limburg Renal Registry","volume":"66","author":"van Paassen","year":"2004","journal-title":"Kidney Int"},{"key":"B24-20250825","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/ndt\/17.9.1594","article-title":"Frequency of renal pathology in Spain 1994-1999","volume":"17","author":"Rivera","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B25-20250825","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/ckj\/sfz132","article-title":"Clinical parameters predicting complications in native kidney biopsies","volume":"13","author":"Peters","year":"2019","journal-title":"Clin Kidney J"},{"key":"B26-20250825","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10157-012-0746-8","article-title":"Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010","volume":"17","author":"Sugiyama","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"B27-20250825","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12882-017-0810-4","article-title":"Distribution of glomerular diseases in Taiwan: Preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology","volume":"19","author":"Chiu","year":"2018","journal-title":"BMC Nephrol"},{"key":"B28-20250825","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2369-14-236","article-title":"An overview of the British Columbia Glomerulonephritis network and registry: Integrating knowledge generation and translation within a single framework","volume":"14","author":"Barbour","year":"2013","journal-title":"BMC Nephrol"},{"key":"B29-20250825","doi-asserted-by":"crossref","first-page":"e0206637","DOI":"10.1371\/journal.pone.0206637","article-title":"Temporal trends in biopsy proven glomerular disease in Uruguay, 1990-2014","volume":"13","author":"Garau","year":"2018","journal-title":"PLoS One"},{"key":"B30-20250825","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2215\/CJN.05480421","article-title":"Noninvasive diagnosis of PLA2R-associated membranous nephropathy: A validation study","volume":"16","author":"Bobart","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B31-20250825","doi-asserted-by":"crossref","first-page":"220","DOI":"10.34067\/KID.0000792019","article-title":"Glomerular diseases in patients with diabetes mellitus: An underappreciated epidemic","volume":"1","author":"Freeman","year":"2020","journal-title":"Kidney360"}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005882022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T19:58:11Z","timestamp":1786478291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0005882022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0005882022","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"2022-09-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}